Protocol # NU 98B1: A Phase II Study of Taxotere, Doxrubicin and Cyclophosphamide (TAC) Primary Therapy in Stage III Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date3/3/99 → 1/1/11

Funding

  • Rhone-Poulenc Rorer (NU 98B1)